Researchers tagged mouse RNA with the enzyme that makes fireflies glow, in hopes of better understanding how viruses and ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.
Using a single-cell sequencing technique, it was possible to characterize the different cell types present in the brain ...
"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...
Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...
Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...
Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking ...